Quality of life outcomes with BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: the DEFINE study.

Kappos, Ludwig; Gold, Ralf; Arnold, Douglas L; Bar-Or, Amit; Giovannoni, Gavin; Selmaj, Krzysztof; Sarda, Sujata P; Agarwal, Sonalee; Zhang, Annie; Sheikh, Sarah I; Seidman, Emily; Dawson, Katherine T

Kappos, Ludwig; Gold, Ralf; Arnold, Douglas L; Bar-Or, Amit; Giovannoni, Gavin; Selmaj, Krzysztof; Sarda, Sujata P; Agarwal, Sonalee; Zhang, Annie; Sheikh, Sarah I; Seidman, Emily; Dawson, Katherine T.

Affiliation

Kappos L; Departments of Neurology and Biomedicine, University Hospital Basel, Switzerland.

Mult Scler ; 20(2): 243-52, 2014 Feb.

Article in En | MEDLINE | ID: mdl-24150779

Subject(s)

Fumarates/therapeutic use; Immunosuppressive Agents/therapeutic use; Multiple Sclerosis, Relapsing-Remitting/drug therapy; Quality of Life; Adult; Dimethyl Fumarate; Double-Blind Method; Female; Humans; Male; Middle Aged; Surveys and Questionnaires

Key words

BG-12; DEFINE; dimethyl fumarate; multiple sclerosis; quality of life; randomized controlled trial; relapsingremitting multiple sclerosis

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quality of Life / Multiple Sclerosis, Relapsing-Remitting / Fumarates / Immunosuppressive Agents Type of study: Clinical_trials Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Mult Scler Journal subject: NEUROLOGIA Year: 2014 Type: Article Affiliation country: Switzerland

Fulltext

XML

PubMed Links

Search on Google